Hepatitis B vaccine in celiac disease: Yesterday, today and tomorrow

World Journal of Gastroenterology

Volumn 19, Issue 6, 2013, Pages 838-845

  Vitaliti, Giovanna ^a   Praticò, Andrea Domenico ^a   Cimino, Carla ^a   Di Dio, Giovanna ^a   Lionetti, Elena ^a   La Rosa, Mario ^a   Leonardi, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Celiac disease; Hepatitis B vaccine; Non responders; Vaccination schedules

Indexed keywords

GLUTEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA B8 ANTIGEN; HLA DQ2 ANTIGEN; HLA DR3 ANTIGEN;

ALLELE; CELIAC DISEASE; DRUG RESPONSE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAPLOTYPE; HEPATITIS; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; VACCINATION;

EID: 84873731645     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i6.838     Document Type: Review

References (70)

1. Bozorgi SH, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, Kargar-Fard H, Sadri M, Alavian SM. Risk factors of viral hepatitis: yet to explore. Transfus Apher Sci 2012; 47: 145-149. [PMID: 22858443]
2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34: 1329-1339. [PMID: 16249217 DOI: 10.1093/ije/dyi206]
3. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262: 369-370. [PMID: 8211155 DOI: 10.1126/science.8211155]
4. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, Fleenor M, Ryder PL, Margolis HS. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002; 185: 713-719. [PMID: 11920288 DOI: 10.1086/339192]
5. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196-204. [PMID: 8988900]
6. Zuckerman J, van Hattum J, Cafferkey M, Gjørup I, Hoel T, Rummukainen ML, Weiland O. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? Lancet Infect Dis 2007; 7: 410-419. [PMID: 17521594 DOI: 10.1016/S1473-3099(07)70136-6]
7. Romano' L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 2011; 43 Suppl 1: S2-S7. [PMID: 21195368 DOI: 10.1016/S1590-8658(10)60685-8]
8. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46: 868-875. [PMID: 18269332]
9. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol 2011; 17: 87-95. [PMID: 21757978 DOI: 10.3350/kjhep.2011.17.2.87]
10. Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A. Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. Res Virol 1997; 148: 109-114. [PMID: 9108609]
11. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 1999; 17: 2661-2666. [PMID: 10418916]
12. Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol 1998; 4: 493-496. [PMID: 11819352]
13. Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001; 19: 2055-2060. [PMID: 11228377 DOI: 10.1016/S0264-410X(00)00410-2]
14. Liu HB, Meng ZD, Ma JC, Han CQ, Zhang YL, Xing ZC, Zhang YW, Liu YZ, Cao HL. A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns. World J Gastroenterol 2000; 6: 381-383. [PMID: 11819603]
15. Wismans PJ, van Hattum J, Mudde GC, Endeman HJ, Poel J, de Gast GC. Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol 1989; 8: 236-240. [PMID: 2523924]
16. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270: 2935-2939. [PMID: 8254853]
17. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993; 270: 2931-2934. [PMID: 8254852]
18. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000; 19: 877-885. [PMID: 11115711 DOI: 10.1016/S0264-410X(00)00224-3]
19. Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999; 179: 1319-1325. [PMID: 10228050 DOI: 10.1086/314768]
20. Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 1999; 29: 954-959. [PMID: 10051503 DOI: 10.1002/hep.510290349]
21. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. J Infect Dis 1997; 175: 674-677. [PMID: 9041341 DOI: 10.1093/ infdis/175.3.674]
22. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366: 1379-1384. [PMID: 16226616 DOI: 10.1016/S01406736(05)67568-X]
23. Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 2007; 25: 3129-3132. [PMID: 17291637 DOI: 10.1016/j.vaccine.2007.01.045]
24. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142: 333-341. [PMID: 15738452]
25. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355: 561-565. [PMID: 10683019 DOI: 10.1016/S0140-6736(99)07239-6]
26. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997; 12: 1204-1211. [PMID: 9198052 DOI: 10.1093/ndt/12.6.1204]
27. Fabrizi F, Dixit V, Magnini M, Elli A, Martin P. Metaanalysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 2006; 24: 497-506. [PMID: 16886915 DOI: 10.1111/j.1365-2036.2006.03002.x]
28. Barraclough KA, Wiggins KJ, Hawley CM, van Eps CL, Mudge DW, Johnson DW, Whitby M, Carpenter S, Playford EG. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis 2009; 54: 95-103. [PMID: 19481320 DOI: 10.1053/j.ajkd.2009.03.010]
29. Poux JM, Ranger-Rogez S, Lagarde C, Benevent D, Denis F, Leroux-Robert C. [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach]. Presse Med 1995; 24: 803-806. [PMID: 7630869]
30. Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine 2009; 27: 6030-6033. [PMID: 19682619 DOI: 10.1016/ j.vaccine.2009.07.099]
31. Leonardi S, Leggio T, Sciacca A, Di Gregorio F, Musumeci S. Intradermal hepatitis B vaccination in thalassaemia. Arch Dis Child 1990; 65: 527-529. [PMID: 2141464]
32. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Infect Dis Clin North Am 2006; 20: 27-45. [PMID: 16527647 DOI: 10.1016/j.idc.2006.01.004]
33. Degos F, Duhamel G, Brechot C, Nalpas B, Courouce AM, Tron F, Berthelot P. Hepatitis B vaccination in chronic alcoholics. J Hepatol 1986; 2: 402-409. [PMID: 2941477]
34. Zuin G, Principi N, Tornaghi R, Paccagnini S, Re M, Massironi E, Ragni MC. Impaired response to hepatitis B vaccine in HIV infected children. Vaccine 1992; 10: 857-860. [PMID: 1455911]
35. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998; 15: 1-8. [PMID: 9651632]
36. Peces R, de la Torre M, Alcázar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 1997; 29: 239-245. [PMID: 9016896]
37. Li Volti S, Caruso-Nicoletti M, Biazzo F, Sciacca A, Mandarà G, Mancuso M, Mollica F. Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch Dis Child 1998; 78: 54-57. [PMID: 9534677 DOI: 10.1136/adc.78.1.54]
38. Bouter KP, Diepersloot RJ, Wismans PJ, Gmelig Meyling FH, Hoekstra JB, Heijtink RA, van Hattum J. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabet Med 1992; 9: 66-69. [PMID: 1532355]
39. Leonardi S, Vitaliti G, Garozzo MT, Miraglia del Giudice M, Marseglia G, La Rosa M. Hepatitis B vaccination failure in children with diabetes mellitus? The debate continues. Hum Vaccin Immunother 2012; 8: 448-452. [PMID: 22370513]
40. Kaukinen K, Halme L, Collin P, Färkkilä M, Mäki M, Vehmanen P, Partanen J, Höckerstedt K. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002; 122: 881-888. [PMID: 11910339]
41. Nemes E, Lefler E, Szegedi L, Kapitány A, Kovács JB, Balogh M, Szabados K, Tumpek J, Sipka S, Korponay-Szabó IR. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics 2008; 121: e1570-e1576. [PMID: 18519462 DOI: 10.1542/peds.2007-2446]
42. Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, Levine J. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr 2007; 44: 431-435. [PMID: 17414139 DOI: 10.1097/ MPG.0b013e3180320654]
43. Ahishali E, Boztas G, Akyuz F, Ibrisim D, Poturoglu S, Pinarbasi B, Ozdil S, Mungan Z. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci 2008; 53: 2156-2159. [PMID: 18157638 DOI: 10.1007/s10620-007-0128-3]
44. Zingone F, Morisco F, Zanetti A, Romanò L, Portella G, Capone P, Andreozzi P, Tortora R, Ciacci C. Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine 2011; 29: 1005-1008. [PMID: 21129395 DOI: 10.1016/ j.vaccine.2010.11.060]
45. Ertekin V, Tosun MS, Selimoglu MA. Is there need for a new hepatiti{dotless}s B vaccine schedule for children with celiac disease? Hepat Mon 2011; 11: 634-637. [PMID: 22140387 DOI: 10.5812/kowsar.1735142X.715]
46. Chen J, Liang Z, Lu F, Fang X, Liu S, Zeng Y, Zhu F, Chen X, Shen T, Li J, Zhuang H. Toll-like receptors and cytokines/ cytokine receptors polymorphisms associate with nonresponse to hepatitis B vaccine. Vaccine 2011; 29: 706-711. [PMID: 21111021 DOI: 10.1016/j.vaccine.2010.11.023]
47. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr 1999; 69: 354-365. [PMID: 10075317]
48. Freeman HJ, Chopra A, Clandinin MT, Thomson AB. Recent advances in celiac disease. World J Gastroenterol 2011; 17: 2259-2272. [PMID: 21633592 DOI: 10.3748/wjg.v17. i18.2259]
49. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006; 55: 1037-1046. [PMID: 16766754 DOI: 10.1136/ gut.2005.075119]
50. Leonardi S, La Rosa M. Are hepatitis B virus and celiac disease linked? Hepat Mon 2010; 10: 173-175. [PMID: 22308135]
51. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007; 46: 1650-1658. [PMID: 17969053]
52. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000; 356: 1494-1495. [PMID: 11081540]
53. Wasmuth HE, Stolte C, Geier A, Gartung C, Matern S. Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis C. Gut 2001; 49: 596-597. [PMID: 11589192]
54. Adinolfi LE, Durante Mangoni E, Andreana A. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 2001; 96: 607-608. [PMID: 11232725]
55. Monteleone G, Pender SL, Alstead E, Hauer AC, Lionetti P, McKenzie C, MacDonald TT. Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 2001; 48: 425-429. [PMID: 11171837]
56. Leonardi S, Longo R, Cotugno M, Tardino L, Spina M, Lionetti E, La Rosa M. [Vaccination and celiac disease: results of a retrospective study]. Minerva Pediatr 2011; 63: 363-367. [PMID: 21946447]
57. Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines. Clin Exp Immunol 2000; 122: 390-399. [PMID: 11122245 DOI: 10.1046/j.1365-2249.2000.01383.x]
58. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41: 1383-1390. [PMID: 15915462 DOI: 10.1002/hep.20716]
59. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321: 708-712. [PMID: 2528067]
60. Livenson AR. [Electrical equipment in medical establishments and electrical safety]. Med Tekh 1979; (1): 7-12. [PMID: 763114]
61. Martinetti M, Cuccia M, Daielli C, Ambroselli F, Gatti C, Pizzochero C, Belloni C, Orsolini P, Salvaneschi L. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine 1995; 13: 555-560. [PMID: 7483776]
62. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol 2003; 98: 2289-2292. [PMID: 14572581 DOI: 10.1111/j.1572-0241.2003.07701.x]
63. Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under-and over-diagnosis. Int J Immunopathol Pharmacol 2009; 22: 1-7. [PMID: 19309546]
64. Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoǧlu E, Eksioglu-Demiralp E. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol 2010; 22: 787-793. [PMID: 19584738 DOI: 10.1097/ MEG.0b013e32832e9d41]
65. Dubois B, Bridon JM, Fayette J, Barthélémy C, Banchereau J, Caux C, Brière F. Dendritic cells directly modulate B cell growth and differentiation. J Leukoc Biol 1999; 66: 224-230. [PMID: 10449158]
66. Leonardi S, Del Giudice MM, Spicuzza L, Spina M, La Rosa M. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study. Am J Gastroenterol 2010; 105: 2117-2119. [PMID: 20818367 DOI: 10.1038/ ajg.2010.195]
67. Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, La Rosa M. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 2012; 18: 5729-5733. [PMID: 23155313]
68. WHO Publication. Hepatitis B vaccines: WHO position paper--recommendations. Vaccine 2010; 28: 589-590. [PMID: 19896455]
69. Sangfelt P, Uhnoo I, Reichard O, Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol 2008; 43: 465-472. [PMID: 18365912 DOI: 10.108 0/00365520701733806]
70. Da Villa G, Picciottoc L, Elia S, Peluso F, Montanaro F, Maisto T. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field. Vaccine 1995; 13: 1240-1243. [PMID: 8578810]